It was into up cycle since the AGM. The yearly MA became good support.
broker, MB
Action and recommendation
• Upgrade to Outperform (from Neutral).
Earnings and target price revision
• FY21/22/2 EPS n.m./+24%/+14% driven by cost benefits/ op leverage. PT
upgraded to $20.00 (from $15.30), reflecting earnings changes & reduced
risk discount in FY24 (by 1/3) with vaccine rollout now underway.
It was into up cycle since the AGM. The yearly MA became good...
Add FLT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.42 |
Change
-0.220(1.07%) |
Mkt cap ! $4.512B | |||
| Open | High | Low | Value | Volume |
| $20.55 | $20.81 | $20.42 | $16.48M | 802.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $20.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.52 | 6379 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.59 |
Change
-0.220 ( 0.71 %) |
||||
| Open | High | Low | Volume | ||
| $20.60 | $20.81 | $20.58 | 86801 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| FLT (ASX) Chart |